bis(5-amidino-2-benzimidazolyl)methane has been researched along with Granulomatous Disease, Chronic in 2 studies
bis(5-amidino-2-benzimidazolyl)methane: aromatic diamidine which has a significant suppressive effect on the cytopathology & yield of respiratory synctial (RS) virus; RN given refers to parent cpd
Granulomatous Disease, Chronic: A defect of leukocyte function in which phagocytic cells ingest but fail to digest bacteria, resulting in recurring bacterial infections with granuloma formation. When chronic granulomatous disease is caused by mutations in the CYBB gene, the condition is inherited in an X-linked recessive pattern. When chronic granulomatous disease is caused by CYBA, NCF1, NCF2, or NCF4 gene mutations, the condition is inherited in an autosomal recessive pattern.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Geratz, JD | 2 |
Tidwell, RR | 2 |
Lombardy, RJ | 1 |
Schwab, JH | 2 |
Anderle, SK | 2 |
Pryzwansky, KB | 2 |
2 other studies available for bis(5-amidino-2-benzimidazolyl)methane and Granulomatous Disease, Chronic
Article | Year |
---|---|
Streptococcal cell wall-induced systemic disease. Beneficial effects of trans-bis(5-amidino-2-benzimidazolyl)ethene, a novel, macrophage-directed anti-inflammatory agent.
Topics: Animals; Benzimidazoles; Cell Membrane; Female; Granulomatous Disease, Chronic; Inflammation; Liver; | 1991 |
Suppression of streptococcal cell wall-induced arthritis by a potent protease inhibitor, bis(5-amidino-2-benzimidazolyl)methane.
Topics: Animals; Anti-Inflammatory Agents; Arthritis; Arthritis, Experimental; Benzimidazoles; Cell Wall; Ch | 1988 |